Australia TGA ARTG recordOesophageal intubation detector, exhaled carbon dioxide, adult
Australia TGA ARTG Registered Device · Cardinal Health Australia 503 Pty Ltd · Cardinal Health 200 LLC · Class I · Started June 14, 2024
Good Name: Cardinal Health Australia 503 Pty Ltd - Oesophageal intubation detector, exhaled carbon dioxide, adult
- Risk Class
- Class I
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- June 14, 2024
- Effective Date
- June 14, 2024
- Country
- United States of America
- Address
- 3651 Birchwood Drive, Waukegan, Illinois, 60085
An accessory to a gastric tube to assist in the determination of proper tube placement by detecting carbon dioxide (CO2) in the gas present at the tip of the tube. This device is used to assist verification of tube placement during nasal/oral gastric tube placement in adults and helps avoid inadvertent tracheal placement.
Access comprehensive regulatory information for Oesophageal intubation detector, exhaled carbon dioxide, adult in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Cardinal Health Australia 503 Pty Ltd, manufactured by Cardinal Health 200 LLC in United States of America. The device registration started on June 14, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.